Understanding the underlying molecular mechanism of how the AMPK/NF-κB pathway and related NLRP3 inflammasome affect obesity and obesity-induced inflammation might lead to preventive strategy for obesity-mediated metabolic diseases. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.